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Abstract
Background: Bacterial invasion during sepsis induces disregulated systemic responses that could
lead to fatal lung failure. The purpose of this study was to relate the temporal dynamics of gene
expression to the pathophysiological changes in the lung during the first and second stages of E. coli
sepsis in baboons.
Results: Using human oligonucleotide microarrays, we have explored the temporal changes of
gene expression in the lung of baboons challenged with sublethal doses of E. coli. Temporal
expression pattern and biological significance of the differentially expressed genes were explored
using clustering and pathway analysis software. Expression of selected genes was validated by real-
time PCR. Cytokine levels in tissue and plasma were assayed by multiplex ELISA. Changes in lung
ultrastructure were visualized by electron microscopy. We found that genes involved in primary
inflammation, innate immune response, and apoptosis peaked at 2 hrs. Inflammatory and immune
response genes that function in the stimulation of monocytes, natural killer and T-cells, and in the
modulation of cell adhesion peaked at 8 hrs, while genes involved in wound healing and functional
recovery were upregulated at 24 hrs.
Conclusion: The analysis of gene expression modulation in response to sepsis provides the
baseline information that is crucial for the understanding of the pathophysiology of systemic
inflammation and may facilitate the development of future approaches for sepsis therapy.
Background
Sepsis and its complications represent a complex disease
encompassing multiple pathological processes, including
uncontrolled systemic inflammation, coagulopathy,
microvascular and hemodynamic abnormalities. The
development of septic shock, acute respiratory distress
syndrome (ARDS) and the onset of multiple organ (lung,
liver, kidney, heart) dysfunction (MOD) are landmarks of
severe sepsis, one of the leading causes of mortality in crit-
ically ill patients[1]. Despite significant progress, the
pathophysiology of sepsis and its sequels are still not fully
understood. One early MOD symptom associated with
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sepsis is acute lung injury[2]. Lipopolysaccharide (LPS)
was considered the main component in the induction of
lung injury in gram-negative bacterial sepsis. LPS recogni-
tion by host's Toll-Like Receptors (TLRs) is followed by
subsequent activation of a plethora of signal transduction
cascades in different lung cells[3], leading to the genera-
tion of a multitude of inflammatory mediators, including
proinflammatory cytokines, chemokines, adhesion mole-
cules, reactive oxygen species and nitric oxide[4,5]. This
process is accompanied by massive influx of neutrophils
and macrophages into the lung, and by severe damage to
the lung endothelium and alveolar epithelium[6,7].
Other mediators including microbial signal molecules,
complement activation products, and coagulation factors
play a critical role in the pathophysiology of sepsis[8,9].
However, neither the full spectrum of mediators acting in
multiple pathways nor the temporal expression pattern of
each individual mediator, alone or in combination, are
clear to date. Understanding the pathogenesis of sepsis
has been particularly challenging as this involves multiple
functional pathways, comprising hundreds of genes. We
reasoned that microarray technology would likely provide
novel insights into the pathogenesis of sepsis or acute
lung injury by allowing genomic-scale analysis of the gene
transcription in specific organs. In the past, this technol-
ogy has been used to study the pattern of gene expression
either on cells exposed in vitro to LPS [10-13] or E.
coli[14], or on blood cells isolated from septic
patients[15]. So far, global gene expression studies in ani-
mal models of sepsis have been limited and restricted to
rodents[2,6,16]. However, mouse models do not reflect
the pathophysiology of the disease in humans (e.g., mice
do not produce IL-8, which is a major proinflammatory
chemokine in humans). Our laboratory had characterized
a baboon model of compensated (non-lethal) E. coli sep-
sis, which is comparable in nearly all physiological and
immunological aspects to human disease. Similar to
humans, the baboon model of compensated response to
inflammatory stress exhibits two stages, each with its
unique inflammatory and haemostatic response signa-
ture[17]. Baboon-specific microarrays are not available,
yet, but given the close evolutionary relationship between
baboons and humans, human microarrays have been suc-
cessfully used to study gene expression patterns in non-
human primates [18-21] and several cross-hybridization
studies between these species have been attempted [22-
24]. Using the baboon model of sepsis, here, we report for
the first time a global analysis of gene expression patterns
in the lung of baboons during the first 24 hrs post E. coli
challenge. The purpose of this study was to relate the tem-
poral dynamics of gene expression in the lung to what we
already have learned in previous studies about the com-
pensated response of the baboon to sublethal E. coli chal-
lenge. Our results provide information relating to the
temporal changes of the gene expression during inflam-
mation in response to E. coli infusion, which could serve
as a basis for discovery of new diagnostic and prognostic
indicators and biomarkers, as well as the identification
and validation of new molecular targets for drug develop-
ment.
Results
1. Global analysis of gene expression profile in baboon 
septic lung
Oligonucleotide microarrays were used to study the time-
course of gene expression in the lung of baboons chal-
lenged with E. coli. Approximately one third of the genes
on the chip (7240 out of 21,423) were detectable above
the background.
Genes up- or down-regulated more than 2 times over con-
trols at any time-point (Figures 1a and 1b) were consid-
ered differentially expressed. At 2 hrs after E. coli
challenge, expression of 83 genes was modulated by treat-
ment (70 up- and 13 down-regulated); at 8 hrs, 193 (110
genes up- and 83 down-regulated); and at 24 hrs, 256
(113 up- and 142 down-regulated). Four genes (S100A8,
S100A9, WARS, GBP2 and CCL3L1) were up-regulated
and two genes (THBD and SPARCL1) were down-regu-
lated at all three time points. The genes up-regulated dur-
ing the time-course of the experiment are listed in Table 1,
and the down-regulated genes are listed in Table 2. Most
of down-regulated genes (95%) were detected in the lung
at 8 hrs and 24 hrs. These genes are involved in inflamma-
tion and immune response, protein scaffolding and blood
coagulation, collagen and extracellular matrix catabolism,
cell adhesion and migration, cell cycle, stress response,
protein transport and synthesis, energy generation and
transcriptional regulation (Table 2).
2. Validation of microarray results by real time RT-PCR
To confirm the microarray results, the expression level of
nine genes was measured by real-time quantitative RT-
PCR using the same mRNA samples used for microarray
analysis. The primer sequences of these genes are listed in
Table 3. Microarray and real-time PCR data were highly
concordant (Table 4).
3. Functional analysis of gene expression in lung during E. 
coli sepsis
Inflammatory/immune response genes
a. Induced proinflammatory proteins
At 2 hrs, 25 of the 70 up-regulated genes belong to the
inflammatory/immune pathway (Table 2; Figure 1a). Five
of the most highly up-regulated genes were chemokines
(CXCL2, CCL20) or inflammation-associated genes
(S100A8, S100A9, GBP2). Other genes up-regulated at 2
hrs include CXCL2, CCL20, IL1B, CXCL10, CCL2, IL6,
IL15RA. Genes upregulated only at 8 hrs include CXCL11,BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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IRF1, VCAM1, CLECSF5, GBP1, S100A9, while GBP2 and
S100A8 were up-regulated at both 8 hrs and 24 hrs.
b. Induced antinflammatory proteins
Three TNF-α modulators, TNFAIP2, TNFAIP3 (TNF-α-
induced proteins 2 and 3) and TNIP1 (TNFAIP3 interact-
ing protein 1) were upregulated at 2 hrs. TNFAIP2 may
play a pro-angiogenic role, whereas TNFAIP3 interacts
with TNIP1 and inhibits TNF-induced NFk-B-dependent
gene expression by interfering with RIP- or TRAF2-medi-
ated transactivation signal. The complex acts as an inhibi-
tor of apoptosis, has a role in the function of the
lymphoid system and may contribute to the in vivo effects
of TNF-α.
Two other NFk B inhibitors (NFKBIA and NFKBIE) were
upregulated at 2 hrs by 6.2-fold and 2.4 fold, respectively.
These proteins inhibit NFk-B by complexing with and
trapping it in the cytoplasm. They may be involved in reg-
ulation of transcriptional responses to NFk-B, including
cell adhesion, immune and proinflammatory responses,
apoptosis, differentiation and growth. IL15 RA (IL15
receptor α, 2.2-fold increase at 2 hrs) signals through Jak-
STAT pathway and plays a role in IL15-mediated T-cell
proliferation and differentiation of natural killer cells. Its
ligand, IL-15 is a potent inhibitor of TNF-mediated apop-
tosis and has a protective effect against E. coli induced
shock [25]. IL1RN (IL-1 receptor antagonist; 2.8-fold
increase at 2 hrs) is a protein secreted mainly by macro-
phages that acts as competitive inhibitor of IL-1β binding
to its cell-surface receptor. Thus, IL1RN functions as a
major naturally occurring anti-inflammatory protein.
c. Suppressed inflammatory genes
Decreased expression of a group of inflammatory
response genes, including TNFRSF8, CXCL5, C7, HLA-
DRB3 was observed at 8 and 24 hrs. TNFSF8/CD30L, a
member of the TNF receptor superfamily that regulates
gene expression through activation of NFk-B, may play a
role in the regulation of cellular growth and transforma-
tion of activated lymphoblasts. C7 is a complement com-
ponent that binds to C5b forming the membrane attack
complex C5b-7. HLA-DRB3 is a component of the major
histocompatibility complex class II and is essential in pre-
senting bacterial antigen to CD4-positive lymphocytes.
Hypoxia, oxidative stress and apoptosis genes
Several genes that have function related to hypoxia and
oxidative stress, including HIF1A, TXNRD1, SOD2 and
HP, were induced during the time-course of the experi-
ment. HIF1A (2.9-fold increase at 2 hrs) functions as a
master transcriptional regulator of the adaptive response
Venn diagram of the differentially expressed genes in the E. coli challenged septic baboons Figure 1
Venn diagram of the differentially expressed genes in the E. coli challenged septic baboons. a: genes up-regulated; 
b: genes down-regulated at three time points.BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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Table 1: Genes up-regulated by sepsis in the lung of the baboons at 2, 8 and 24 hr post E. coli challenge
Gene Accession no. Gene Product Fold change compared to control
2 h 8 h 24 h
Cytokine or chemokine
NM_002089 chemokine (C-X-C motif) ligand 2 (CXCL2) 10.8
NM_004591 chemokine (C-C motif) ligand 20 (CCL20) 8.3
NM_000576 interleukin 1, beta (IL1B) 4.5
NM_005409 chemokine (C-X-C motif) ligand 11 (CXCL11) 4.4 10.5
NM_001565 chemokine (C-X-C motif) ligand 10 (CXCL10) 4.3
NM_002982 chemokine (C-C motif) ligand 2 (CCL2) 3.5
NM_002198 interferon regulatory factor 1 (IRF1) 3.0 3.8
NM_000600 interleukin 6 (interferon, beta 2) (IL6) 2.2
NM_002189 interleukin 15 receptor, alpha (IL15RA) 2.2
NM_002984 chemokine (C-C motif) ligand 4 (CCL4) 2.2
NM_000759 colony stimulating factor 3 (granulocyte) (CSF3) 4.4
D90145 chemokine (C-C motif) ligand 3-like 1(CCL3L1) 2.6 3.0 2.0
Cytokine suppression or regulation
X52015 interleukin 1 receptor antagonist (IL1RN) 2.8
Adhesion molecules
NM_001078 vascular cell adhesion molecule 1 (VCAM1) 6.9 4.7
NM_000201 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor (ICAM1) 3.5
NM_001816 carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8) 2.0
NM_021219 junctional adhesion molecule 2 (JAM2) 2.0 2.3
NM_003370 vasodilator-stimulated phosphoprotein (VASP) 2.3 2.1
AF139768 C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily 
member 5
2.01
NM_002999 syndecan 4 (amphiglycan, ryudocan) (SDC4) 6.0
Other inflammation-associated genes
NM_004120 guanylate binding protein 2, interferon-inducible (GBP2) 10.2 16.3 2.3
NM_002053 guanylate binding protein 1, interferon-inducible, 67 kDa (GBP1) 3.8 4.5
NM_006291 tumor necrosis factor, alpha-induced protein 2 (TNFAIP2) 3.4
NM_006058 TNFAIP3 interacting protein 1 (TNIP1) 2.9
NM_006290 tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) 2.5
NM_003821 receptor-interacting serine-threonine kinase 2 (RIPK2) 2.1
NM_002964 S100 calcium binding protein A8 (calgranulin A) (S100A8) 12.0 27.5 6.2
NM_002965 S100 calcium binding protein A9 (calgranulin B) (S100A9) 7.7 17.5
NM_007053 CD160 antigen (CD160) 2.2 2.0
NM_001276 chitinase 3-like 1 (cartilage glycoprotein-39) (CHI3L1) 3.2 2.5
NM_004271 lymphocyte antigen 86 (LY86) (MD-1) 2.3
NM_001085 serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, 
antitrypsin), member 3 (SERPINA3)
5.6 6.8
NM_002818 proteasome (prosome, macropain) activator subunit 2 (PA28 beta) (PSME2) 3.1
NM_004159 proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional 
protease 7) (PSMB8)
3.2
Hypoxia and/or oxidative stress
NM_001530 hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription 
factor) (HIF1A)
2.9 2.5
NM_003330 thioredoxin reductase 1 (TXNRD1) 2.1
NM_000636 superoxide dismutase 2, mitochondrial (SOD2) 12.5 5.0BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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AK055872 Haptoglobin (HP) 33.3 24.4
Apoptosis
AF070674 baculoviral IAP repeat-containing 3 (BIRC3) 2.9
NM_015675 growth arrest and DNA-damage-inducible, beta (GADD45B) 3.0
NM_002727 proteoglycan 1, secretory granule (PRG1) 2.3 2.4
NM_052889 CARD only protein (COP) 9.6 11.8
NM_003311 pleckstrin homology-like domain, family A, member 2 (PHLDA2) 3.1
NM_005734 homeodomain interacting protein kinase 3 (HIPK3) 2.0
NM_016426 G-2 and S-phase expressed 1 (GTSE1) 2.0
NM_005456 mitogen-activated protein kinase 8 interacting protein 1 (MAPK8IP1) 2.3
Heat shock protein
NM_014365 heat shock 27 kDa protein 8 (HSPB8) 3.0 2.7
Cell proliferation tumor suppressor wound healing process
NM_003311 pleckstrin homology-like domain, family A, member 2 (PHLDA2) 2.8
NM_021077 neuromedin B (NMB) 2.0
NM_006069 murine retrovirus integration site 1 homolog (MRVI1) 2.7
NM_001260 cyclin-dependent kinase 8 (CDK8) 2.7
NM_003073 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily b, member 1 (SMARCB1)
2.4
AK055327 fibroblast activation protein, alpha (FAP) 4.3
NM_005424 tyrosine kinase with immunoglobulin and epidermal growth factor homology 
domains (TIE)
2.9
NM_002408 mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 
(MGAT2)
2.9
NM_020638 fibroblast growth factor 23 (FGF23) 2.3
NM_006603 stromal antigen 2 (STAG2) 2.3
NM_005622 SA hypertension-associated homolog (rat) (SAH) 2.3
AB011537 slit homolog 1 (Drosophila) (SLIT1) 2.2
J05158 carboxypeptidase N, polypeptide 2, 83 kD (CPN2) 2.1
AF339822 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular 
permeability factor receptor) (FLT1)
2.2 3.2
AK056352 PR domain containing 5 (PRDM5) 2.0 2.5
AL117643 activin A receptor, type IB (ACVR1B) 2.4
Coagulation
NM_001993 coagulation factor III (thromboplastin, tissue factor) (F3) 2.5
NM_014059 response gene to complement 32 (RGC32) 3.7
Blood pressure
NM_024409 natriuretic peptide precursor C (NPPC) 2.8
Energy generation
AF327403 solute carrier family 25, member 28 (SLC25A28) 2.1
NM_000761 cytochrome P450, family 1, subfamily A, polypeptide 2 (CYP1A2) 3.5 3.4
AL359600 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 (ABCC5) 2.3
AF052090 nicotinamide nucleotide transhydrogenase (NNT) 2.7
NM_004297 guanine nucleotide binding protein (G protein), alpha 14 (GNA14) 2.1
Protein synthesis
AL161952 glutamate-ammonia ligase (glutamine synthase) (GLUL) 2.1
NM_004184 tryptophanyl-tRNA synthetase (WARS) 2.1 8.0 3.4
NM_002954 ribosomal protein S27a (RPS27A) 2.1
Table 1: Genes up-regulated by sepsis in the lung of the baboons at 2, 8 and 24 hr post E. coli challenge (Continued)BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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NM_013417 isoleucine-tRNA synthetase (IARS) 2.0
Cation transporter
NM_017964 solute carrier family 30 (zinc transporter), member 6 (SLC30A6) 2.0
NM_022154 solute carrier family 39 (zinc transporter), member 8 (SLC39A8) 4.4 3.6
D31887 solute carrier family 39 (zinc transporter), member 14 (SLC39A14) 2.2
Transcriptional regulation
NM_020529 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 
(NFKBIA)
6.2
AK026497 YY1 transcription factor (YY1) 2.6
NM_004556 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon 
(NFKBIE)
2.4
NM_013448 bromodomain adjacent to zinc finger domain, 1A (BAZ1A) 2.0
NM_015859 general transcription factor IIA, 1, 19/37 kDa (GTF2A1) 2.1
NM_004697 PRP4 pre-mRNA processing factor 4 homolog (yeast) (PRPF4) 2.7
NM_005523 homeo box A11 (HOXA11) 2.1
NM_006540 nuclear receptor coactivator 2 (NCOA2) 3.5
NM_012345 nuclear fragile × mental retardation protein interacting protein 1 (NUFIP1) 3.4
NM_004719 splicing factor, arginine/serine-rich 2, interacting protein (SFRS2IP) 3.3
NM_004514 forkhead box K2 (FOXK2) 3.1
BG163465 I-mfa domain-containing protein (HIC) 2.0
AK025842 nuclear receptor subfamily 2, group F, member 2 (NR2F2) 2.0
Cell motility, phagocytosis, trafficking
NM_002356 myristoylated alanine-rich protein kinase C substrate (MARCKS) 3.0
NM_006086 tubulin, beta, 4 (TUBB4) 2.5 3.5
AK023457 RAP1A, member of RAS oncogene family (RAP1A) 2.7
Lipid
AF323540 apolipoprotein L, 1 (APOL1) 3.7 12.4
NM_005564 lipocalin 2 (oncogene 24p3) (LCN2) 8.6 10.7
NM_004190 lipase, gastric (LIPF) 2.1
Protein glycosylation
NM_004737 like-glycosyltransferase (LARGE) 2.3
AB067505 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 13 (GalNAc-T13)
2.0
NM_006042 heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 (HS3ST3A1) 2.1
AF155510 Heparanase (HPSE) 2.1
NM_005424 yrosine kinase with immunoglobulin and epidermal growth factor homology 
domains (TIE)
2.9
NM_002408 mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 
(MGAT2)
2.9
NM_006577 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) 3.3
Signal transduction
NM_002401 mitogen-activated protein kinase kinase kinase 3 (MAP3K3) 3.0
NM_001721 BMX non-receptor tyrosine kinase (BMX) 2.6
NM_004297 guanine nucleotide binding protein (G protein), alpha 14 (GNA14) 2.1
NM_002075 guanine nucleotide binding protein (G protein), beta polypeptide 3 (GNB3) 2.6 2.2
BC011671 guanine nucleotide binding protein (G protein), beta 5 (GNB5) 2.7
NM_004125 guanine nucleotide binding protein (G protein), gamma 10 (GNG10) 2.2 2.5
NM_005279 G protein-coupled receptor 1 (GPR1) 3.3
Table 1: Genes up-regulated by sepsis in the lung of the baboons at 2, 8 and 24 hr post E. coli challenge (Continued)BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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Table 2: Genes downregulated by sepsis in the lung of the baboons at 2, 8 and 24 hrs post E. coli challenge
Gene Accession no. Gene Product Fold change compared to control
2 h 6–8 h 24 h
Cytokine, chemokine, inflammation associated gene
NM_001243 tumor necrosis factor receptor superfamily, member 8 (TNFRSF8) 0.23 0.18
NM_000014 alpha-2-macroglobulin (A2M) 0.48
NM_002994 chemokine (C-X-C motif) ligand 5 (CXCL5) 0.50
NM_004763 integrin beta 1 binding protein 1 (ITGB1BP1) 0.50
Immune response
NM_000587 complement component 7 (C7) 0.32
NM_002125 major histocompatibility complex, class II, DR beta 3 (HLA-DRB3) 0.33
Scaffolding protein
NM_001753 Caveolin 1 protein (CAV1) 0.49
Blood coagulation
NM_000361 Thrombomodulin (THBD) 0.39 0.17 0.25
NM_000611 CD59 antigen p18–20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, 
EJ30, EL32 and G344) (CD59)
0.42
NM_001150 alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, 
microsomal aminopeptidase) (ANPEP)
0.43
Collagen catabolism, extra cellular matrix
NM_004530 matrix metalloproteinase 2 (gelatinase A, 72 kDa gelatinase, 72 kDa type IV 
collagenase) (MMP2)
0.36 0.36
AL110197 tissue inhibitor of metalloproteinase 2 (TIMP2) 0.46 0.45
NM_001848 collagen, type VI, alpha 1 (COL6A1) 0.48
NM_004369 collagen, type VI, alpha 3 (COL6A3) 0.30
NM_000362 tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, 
pseudoinflammatory) (TIMP3)
0.32
Cell adhesion, cell migration
NM_001901 connective tissue growth factor (CTGF) 0.37
AY027862 upregulated in colorectal cancer gene 1 (UCC1) 0.40
NM_001769 CD9 antigen (p24) (CD9) 0.30
NM_002026 fibronectin 1 (FN1) 0.37
AL050364 plakophilin 4 (PKP4) 0.44 0.43
NM_001305 claudin 4 (CLDN4) 0.46
AF022375 vascular endothelial growth factor (VEGF) 0.40
NM_013994 discoidin domain receptor family, member 1 (DDR1) 0.44
NM_014000 Vinculin (VCL) 0.50
Anti-inflammation
AB025432 delta sleep inducing peptide, immunoreactor (DSIPI) 0.41 0.39
Cell growth, proliferation, differentiation, cell cycle
NM_001946 dual specificity phosphatase 6 (DUSP6) 0.45
NM_002165 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1) 0.34
NM_006286 transcription factor Dp-2 (E2F dimerization partner 2) (TFDP2) 0.37
NM_002276 keratin 19 (KRT19) 0.35
NM_001424 epithelial membrane protein 2 (EMP2) 0.42 0.44
NM_001431 erythrocyte membrane protein band 4.1-like 2 (EPB41L2) 0.42
NM_005610 retinoblastoma binding protein 4 (RBBP4) 0.45 0.45
NM_006407 cytoskeleton related vitamin A responsive protein (JWA) 0.45
AL122055 cyclin-dependent kinase (CDC2-like) 11 (CDK11) 0.45
NM_016250 NDRG family member 2 (NDRG2) 0.46
AF368463 carboxypeptidase M (CPM) 0.47 0.47
NM_005708 glypican 6 (GPC6) 0.49
NM_006835 cyclin I (CCNI) 0.20
AB023182 serine/threonine kinase 38 like (STK38L) 0.32 0.11
AF218029 H3 histone, family 3B (H3.3B) (H3F3B) 0.22
NM_001431 erythrocyte membrane protein band 4.1-like 2 (EPB41L2) 0.25
NM_006185 nuclear mitotic apparatus protein 1 (NUMA1) 0.36BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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NM_001553 insulin-like growth factor binding protein 7 (IGFBP7) 0.37
NM_001980 Epimorphin (EPIM) 0.38
AK055976 thymosin, beta 4, X-linked (TMSB4X) 0.40
NM_005778 RNA binding motif protein 5 (RBM5) 0.41
NM_014399 transmembrane 4 superfamily member 13 (TM4SF13) 0.41
NM_006791 mortality factor 4 like 1 (MORF4L1) 0.47
Transcriptional regulation
NM_001271 chromodomain helicase DNA binding protein 2 (CHD2) 0.38
NM_003924 paired-like homeobox 2b (PHOX2B) 0.41 0.43
AJ420430 general transcription factor IIIC, polypeptide 4, 90 kDa (GTF3C4) 0.41
NM_002938 ring finger protein 4 (RNF4) 0.44 0.28
D49835 ras responsive element binding protein 1 (RREB1) 0.49
NM_002624 prefoldin 5 (PFDN5) 0.32
NM_003418 zinc finger protein 9 (a cellular retroviral nucleic acid binding protein) (ZNF9) 0.34
NM_031243 heterogeneous nuclear ribonucleoprotein A2/B1 (HNRPA2B1) 0.36
NM_003151 signal transducer and activator of transcription 4 (STAT4) 0.38
AB058726 PHD finger protein 6 (PHF6) 0.34 0.39
NM_002228 v-jun sarcoma virus 17 oncogene homolog (avian) (JUN) 0.40
NM_003205 transcription factor 12 (HTF4, helix-loop-helix transcription factors 4) (TCF12) 0.43
NM_031314 heterogeneous nuclear ribonucleoprotein C (C1/C2) (HNRPC) 0.43
NM_001300 core promoter element binding protein (COPEB) 0.45
AL133574 TEA domain family member 1 (SV40 transcriptional enhancer factor) (TEAD1) 0.45
AK027071 transforming growth factor beta-stimulated protein TSC-22 (TSC22) 0.46
AJ420430 general transcription factor IIIC, polypeptide 4, 90 kDa (GTF3C4) 0.50
Apoptosis, stress response
NM_000581 glutathione peroxidase 1 (GPX1) 0.30
NM_000041 apolipoprotein E (APOE) 0.36
NM_004394 death-associated protein (DAP) 0.40
NM_000851 glutathione S-transferase M5 (GSTM5) 0.45
NM_021003 protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform 
(PPM1A)
0.48
Energy generation or protein synthesis
NM_020041 solute carrier family 2 (facilitated glucose transporter), member 9 (SLC2A9) 0.42
AL136693 cytochrome b reductase 1 (CYBRD1) 0.42
NM_002164 indoleamine-pyrrole 2,3 dioxygenase (INDO) 0.44 0.29
AF113701 ribosomal protein L22 (RPL22) 0.49
NM_021194 solute carrier family 30 (zinc transporter), member 1 (SLC30A1) 0.49
NM_000971 ribosomal protein L7 (RPL7) 0.22
NM_015994 ATPase, H+ transporting, lysosomal 34 kDa, V1 subunit D (ATP6V1D) 0.31
NM_001010 ribosomal protein S6 (RPS6) 0.32
NM_001867 cytochrome c oxidase subunit VIIc (COX7C) 0.35
NM_020041 solute carrier family 2 (facilitated glucose transporter), member 9 (SLC2A9) 0.38
NM_001967 eukaryotic translation initiation factor 4A, isoform 2 (EIF4A2) 0.42
NM_001961 eukaryotic translation elongation factor 2 (EEF2) 0.43
NM_001418 eukaryotic translation initiation factor 4 gamma, 2 (EIF4G2) 0.43
NM_003753 eukaryotic translation initiation factor 3, subunit 7 zeta, 66/67 kDa (EIF3S7) 0.43
NM_001460 flavin containing monooxygenase 2 (FMO2) 0.45
AK057575 solute carrier family 25 (mitochondrial carrier* phosphate carrier), member 3 
(SLC25A3)
0.46
AK057299 dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase 
complex) (DLAT)
0.48
NM_016091 eukaryotic translation initiation factor 3, subunit 6 interacting protein (EIF3S6IP) 0.50
Cardiovascular calcifications
NM_000900 matrix Gla protein (MGP) 0.25 0.19
Protein transport
NM_001282 adaptor-related protein complex 2, beta 1 subunit (AP2B1) 0.38
NM_004914 RAB36, member RAS oncogene family (RAB36) 0.40
NM_002865 RAB2, member RAS oncogene family (RAB2) 0.34
AK057157 RAB6A, member RAS oncogene family (RAB6A) 0.25
AK000757 sortilin 1 (SORT1) 0.47
Table 2: Genes downregulated by sepsis in the lung of the baboons at 2, 8 and 24 hrs post E. coli challenge (Continued)BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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to hypoxia. Under hypoxic conditions, HIF1A translocates
into the nucleus, where it binds to the hypoxia response
element (HRE) of target gene promoters and activates the
transcription of over 40 genes involved in oxygen delivery
or metabolic adaptation to hypoxia. Upregulation of
HIF1A in the lung reflects the strong ischemic condition
installed in the early hours post E. coli challenge.
Expression of HP (haptoglobin) was increased 33.3-fold
at 2 hrs (second highest induced gene) and 24.4-fold at 8
hrs. HP binds free hemoglobin released from erythrocytes
with high affinity and thereby inhibits its oxidative activ-
ity. TXNRD1 (thioredoxin reductase; 2.1-fold increase at 2
hrs) is a key enzyme in the regulation of the intracellular
redox environment, and protects against oxidative stress.
SOD2 (mitochondrial superoxide dismutase; 12.5 and 5-
fold increase at 2 and 24 hrs, respectively) plays a key role
in free radical detoxification by destroying toxic free radi-
cals produced within cells during sepsis.
Among the downregulated proteins involved in oxida-
tion, FABP5 (fatty acid-binding protein-5) was decreased
at both 2 hrs and 8 hrs.
With regard to apoptosis, both pro-apoptotic (COP1,
GADD45B and RIPK2) and anti-apoptotic (TNFAIP3 and
BIRC3) genes were induced in the early stages of sepsis.
RIPK2 (CARD-containing IL-1β ICE-kinase) activates
both pro-caspase-1 and pro-caspase-8 and also potenti-
ates CASP-8-mediated apoptosis.
Moreover, the highest increased gene transcript in our
study, IMAGE clone 2363394 (36 and 114 fold at 2 and 8
hrs, respectively) may encode a proapoptotic protein.
Table 4: Gene expression validation using QRT-PCR
Gene Microarrays QRT-PCR Correlation coefficient
0 2 hr 8 hr 24 hr 0 2 hr 8 hr 24 h
TNFAIP3 9.64 23.66 17.60 10.87 1 8.77 4.63 151 0.995
BIRC3 7.77 22.24 14.76 7.23 1 3.79 2.52 1.27 0.993
RIPK2 6.73 14.17 10.43 8.34 1 9.48 5.65 1.24 0.978
SDC4 4.27 25.44 6.77 7.91 1 4.23 1.59 0.84 0.967
THBD 28.10 11.15 4.97 7.09 1 0.3 0.33 0.21 0.958
CAV1 13.31 6.65 7.15 3.44 1 0.64 0.51 0.61 0.843
COP 1.38 13.28 16.27 2.94 1 1.19 3.85 0.18 0.782
S100A8 9.29 111.85 255.40 57.64 1 9.41 8.77 4.96 0.779
HIF1A 6.17 17.79 15.62 7.77 1 2.13 6.66 1.13 0.602
Table 3: Oligonucleotide sequences of the primers used for QRT-PCR
GenBank ID Gene Primer pair sequences
AF070674 BIRC3 F 5'-GTG ATG GTG GAC TCA GGT GTT G-3'
R 5'-TCC TGT CCT TTA ATT CTT ATC AAG TAC TCA-3'
NM052889 COP1 F 5'-CAG GCA GTG CGA GGA CAA-3'
R 5'-AGC AAA GCT TGA TTC TGC CTT CT-3'
NM001530 HIF1A F 5'-CCA AAT CCA GAG TCA CTG GAA CTT-3'
R 5'-CAT CGG AAG GAC TAG GTG TCT GA-3'
NM003821 RIPK2 F 5'-ACG TCT GCA GCC TGG TAT AGC-3'
R 5'-GGC AGG CTT CTG TCA TTT GG-3'
NM002964 S100A8 F 5'-CAA GTC CGT GGG CAT CAT G-3'
R 5'-AGT ACT TGT GGT AGA CGT CGA TGA TAG-3'
NM002999 SDC4 F 5'-GGC AAG AAA CCC ATC TAC AAG AA-3'
R 5'-GCC AGT GCC CAC AAG CA-3'
NM006290 TNFAIP3 F 5'-CTG CCC AGG AAT GCT ACA GAT AC-3'
R 5'-AGG GTC ACC AAG GGT ACA AAA TG-3'
NM001753 CAV1 F 5'-ACA CCG TCT GTG ACC CAC TCT-3'
R 5'-CTG CAA GTT GAT GCG GAC AT-3'
NM000361 THBD F 5'-CCA GCT CTA CTG GTC TTG TGG AA-3'
R 5'-GAT TAA GGC TAG GCC CTA ATT GG-3'
BC013835 β-actin F 5'-AAG CCA CCC CAC TTC TCT CTA A-3'
R 5'-AAT GCT ATC ACC TCC CCT GTG T-3'
Abbreviations: F, forward; R, reverse.BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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Searches for known protein domains and functional
sequence motifs in the putative open reading frame of this
clone, using SMART 4.0[26,27], show perfect homology
with a serine-threonine kinase, STK24, also known as
STE20-like kinase 3 (Mst3), a less known protein kinase
with potential role in the onset of apoptosis[28].
As a general feature, we found that pro-apoptotic genes
predominate during early stages, and anti-apoptotic genes
predominate during the second stage of sepsis. Five genes
encoding apoptosis inhibitors (TNFAIP3, BIRC3 HIPK3,
MAPK8IP1 and LCN2) were up-regulated at different time
points while one gene, DAP, a positive-regulator of apop-
tosis was down-regulated.
Cell adhesion and extracellular matrix (ECM) molecules
During the inflammation, adhesion molecules are
involved in the transmigration of leukocytes through the
vessel wall. Beside the two well characterized adhesion
proteins ICAM1 and VCAM1, CEACAM8 (CD67, a GPI-
anchored protein exclusively expressed on neutrophils
and eosinophils), and SDC4 (syndecan 4, a heparan-sul-
phate proteoglycan) were also up-regulated early in the
inflammatory response. Two other adhesive molecules,
VASP and CLECSF5, were up-regulated at later stages (8
and 24 hrs). VASP is an actin-associated protein that func-
tions in cytoskeleton remodeling during leukocyte-
transendothelial migration. CLECSF5 is a lectin expressed
on macrophages that may be involved in proinflamma-
tory activation of myeloid cells via TYPO-BP mediated sig-
naling.
Decreased mRNA levels of another group of genes (CTGF,
UCC1, PKP4, TNS, CD9, FN1, VCL, ITGB1BP1, claudin 4,
and VEGF) were observed at 8 hrs and 24 hrs. CTGF is a
major connective tissue mitoattractant secreted by
endothelial cells. UCC1 is a calcium-dependent cell adhe-
sion molecule, similar to the protocadherins and epend-
ymins. PKP4 is a component of desmosomes and other
adhesion plaques, and is involved in regulating junctional
plaque organization and cadherin function. TNS (tensin-
1) is localized to focal adhesions, and is thought to play a
role in cell migration by linking signal transduction path-
ways to the cytoskeleton. CD9 is a tetraspanin family
member that makes complexes with integrins and other
tetraspanins, modulates cell adhesion and migration and
also mediates platelet activation and aggregation. FN1
(fibronectin) is a dimeric/multimeric glycoprotein
present in plasma, ECM and on the cell surface, and is
involved in cell adhesion and migration, wound healing,
blood coagulation, and host defense. VCL (vinculin) is a
cytoskeletal protein associated with cell-cell and cell-
matrix junctions, where it is thought to function as one of
the several proteins involved in anchoring F-actin to the
membrane. ITGB1BP1 may play a role in the recruitment
of  β-1 integrins to the focal contacts during integrin-
dependent cell adhesion. Genes with decreased expres-
sion at 8 hrs and 24 hrs include matrix proteins (collagen
VI) or metalloproteainases and their inhibitors (MMP2,
TIMPs 1 and 2).
Regulation of cell growth, transcription and membrane transport
Except for ACVR1 (activin receptor 1B) that was induced
at 2 hours, most of the genes involved in growth regula-
tion and recovering processes were upregulated during the
second stage of sepsis. Genes encoding proteins that are
involved in cell cycle (CDK8, SMARCB1, STAG2), cell
migration (SLIT1), cell proliferation (PHLDA2, NMB,
FAP, TIE), tissue regeneration and remodeling (FGF23),
and protein glycosylation (MGAT2, HPSE, B3GNT1,
HSE3ST3A1, LARGE, GLANT13) were increased almost
exclusively at 24 hrs (Table 2).
Most of the genes encoding for transcriptional regulation
factors, including transcription factors (HOXA11,
FOXK2), transcription repressors (HIC), splicing factors
(PRPF4, SFRS2IP), and nuclear receptors co-activators
(NCOA2, NUFIP1, NR2F2), were also up-regulated at 24
hrs. However, increased expression of transcriptional fac-
tors NFKBIA and NFKBIE (NFKB negative regulators), as
well as of GTF2A1 (general transcriptional factor IIA) are
detected only at 2 and 8 hrs, respectively.
STAT4, a major transcriptional co-regulator of several sig-
naling pathways (STAT, p53, wnt and steroid hormone
signaling) was down-regulated at 24 hrs.
Several ion transporters, including zinc transporters and
members of the solute carrier (SLC) families (SLC25A28,
SLC30A6, SLC39A8, and SLC39A14) are increased during
the early stages of E. coli sepsis. The expression of other
transporters, including SLC2A9 (glucose transporter) and
SLC25A3 (mitochondrial phosphate carrier) was
decreased at 8 hr and 24 hrs.
A decreased expression of several genes involved in the
intracellular trafficking of proteins was observed at 24 hrs.
These included adaptor-related protein complex 2β-1 sub-
unit (AP2B1), a component of the coat surrounding trans-
port membrane vesicles, three members of RAS oncogene
family (RAB2, RAB6A and RAB36), and sortilin 1. The lat-
ter is required for the formation of a specialized storage
vesicle for the glucose transporter SLC2A4/GLUT4.
4. Clustering of gene expression patterns induced by sepsis
Pathologic processes in sepsis fluctuate significantly.
Understanding this complexity may allow enhanced phar-
macologic intervention. Using gene clustering methods
demonstrated that gene expression also changes over time
in complex manner. A gross assessment of expressionBMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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kinetics could be made from a heat-map representation of
differentially expressed genes from all time points. Three
basic expression patterns were observed (Fig. 2). About
40% of the genes were down regulated, 25% of genes were
up regulated and 15% were up and then down regulated.
A list of the genes presented in this map is provided as
Supplementary table 1.
A more detailed analysis of expression changes was done
using a clustering algorithm that identifies clusters of
genes that change in expression in a highly correlated
manner. Ten clusters of genes were identified based on
their expression dynamics during the time-course of the
experimental sepsis (Fig. 2; and Additional file 1). Gene
clusters 1 to 4 contain genes that are downregulated by
sepsis (Fig. 2). Cluster 1 groups 9 genes that reach a max-
imum decrease at 8 hrs and recover at 24 hrs. These genes
are involved in cell cycle (TFDP2, GPC6), tight junctions
(CLDN4), and cell structural integrity (KRT19).
Cluster 2 consists of 34 genes that are decreased at 2–8 hrs
and stay decreased at 24 hrs. These genes are involved in
complement and coagulation cascades (THBD, A2M), cell
adhesion and migration (MMP2, UCC1, CTGF, PKP4,
TNS,) and scaffolding and signaling (CAV1; caveolin 1).
Cluster 3 is the largest (118 genes) and includes genes
involved in inflammation (TNFRSF8, C7, CXCL5,
ITGB1BP1, STAT4), apoptosis and stress (GSTM5, GPX1,
DAP), extracellular matrix (COL6A1, TIMP2, TIMP3), and
cell adhesion and migration (CD9, FN1, and VCL). Genes
in cluster 3 steadily decreased during the time course of
the experiment, except for VEGF, which increased at 2 hrs
then was gradually down-regulated.
Clusters 5 to 10 include genes that are upregulated by E.
coli challenge, as compared to controls. Genes in cluster 5
are upregulated between 2 and 8 hrs, then decrease at 24
hrs. Genes in cluster 6 are steadily upregulated during the
time-course of the experiment, while those in cluster 7 are
strongly upregulated during the mid and second stage.
Clusters 6 and 7 consist of 34 genes each that reach maxi-
mal expression at 24 hrs. Genes in these groups have bio-
logical functions in cell proliferation and wound healing
(FAP, STAG2, and FLT1 in cluster 6; FGF23 and TIE in
cluster 7), signal transduction (MAP3K3, GNA14, GPR1,
GNG10 and MAPK8IP1 in cluster 6; BMX, NMB and
NR2F2 in cluster 7), protein glycosylation (HPSE and
HS3ST3A1 in cluster 6; B3GNT1 and GALNT13 in cluster
7), blood pressure regulation (NPPC), energy pathway
(NNT and GNA14), and inflammation (MD1, lym-
phocyte antigen 86).
Cluster 8 contains genes that peak at 2 hrs, and cluster 9
genes peak at 8 hrs and then gradually decrease. The genes
in cluster 10 peak at 2–8 hrs and generally stay up for the
rest of the time. Cluster 8 contains mainly early responsive
genes, such as cytokines and chemokines (IL6, CXCL2,
CCL2 (MCP-1), IL1B, CCL20, IL1RN, CCL4), inflamma-
tory response genes (RIPK2, SDC4, TNFAIP2, TNIP1,
NFKBIE, TNFAIP3, ICAM1, VCAM1, CEACAM8, NFK-
BIA), stress response (TXNRD1, HIF1A, HP) and apopto-
sis-associated genes (BIRC3, GADD45B). Cluster 9
contains mid-stage induced genes, including many
cytokines and inflammatory response genes, such as
CXCL10, CXCL11, CSF3, S100A8, CLECSF5, S100A9,
IRF1, PSMB8, PSME2, GBP1 and GBP2. While the post-
transcriptional effects of these patterns are more relevant
for designing therapy, it is clear from this analysis that
transcriptional regulation itself is equally complex, and
perhaps models one causal aspect of disease pathology.
Ward's hierarchical cluster analysis of time-dependent gene  expression patterns in the lungs of E. coli challenged versus  control baboons Figure 2
Ward's hierarchical cluster analysis of time-depend-
ent gene expression patterns in the lungs of E. coli 
challenged versus control baboons. a: Differentially 
expressed genes were used in the hierarchical clustering 
analysis by Spotfire DecisionSite 8.1 (Spotfire, Sommerville, 
MA). Wards's method computes cluster proximity by the 
squared Euclidean distance between the gene cluster mean 
profiles. With this method ten clusters of genes with similar 
profiles were generated. See the Additional file 1 for a list of 
genes grouped in each cluster. b: Heat map of hierarchical 
clustering analysis. The hierarchical clustering process is rep-
resented as a tree, or dendrogram, where each step in the 
clustering process is illustrated by a join of the tree. Red 
color indicates a Z-score 1, green color indicates a Z-score 
equal to -1. The colors between red and green indicate Z-
scores between 1 and -1.BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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5. Pathway analysis
Differentially expressed genes were analyzed using path-
way analysis software, which characterizes networks of
genes with common regulatory and signaling capacity.
This allows identification of potentially relevant molecu-
lar processes by visual inspection. Regulatory and signal-
ing networks of genes were created from the differentially
expressed genes at the 2 hrs, 8 hrs and 24 hrs time points.
For each time point several major molecular pathways
were identified. The lists of genes in each network and
their scores are summarized in the Additional files 2, 3, 4.
Moreover, this type of analysis underscores the complex
evolution of molecular processes that occurs in sepsis. At
2 hrs the most significant (score 78) network contained
35 differentially expressed genes. This pathway consists
mainly of pro-inflammatory genes responsive to IL-1β
and IL-6 (Fig. 3a). Three other pathways identified at 2
hours were involved in cell movement, cell proliferation
and death, cell signaling and molecular transport [see
Additional file 2].
At 8 hrs, 8 networks with more than 10 focus genes were
found to be highly significant [see Additional file 3).
These networks were associated with several functions
related to tissue regeneration and homeostasis, including
cell migration, proliferation, membrane transport, cellu-
lar assembly and organization. The network depicted in
Fig. 3b has the highest score (26) and highest number of
focus genes (18 genes; 7 up- and 11 down-regulated), and
is involved in cell movement, cell-cell signaling and inter-
action.
At 24 hrs, 10 networks with more than 10 focus genes
were detected [see Additional file 4]. The highest score
belonged to a network with functions in cardiovascular
development and organismal survival (Fig. 3c). Similar to
the 8 hrs time-point, the major networks expressed at 24
hrs are involved in tissue regeneration and homeostasis
[see Additional file 4].
6. Cytokine profiling in lung and plasma
Since it has been suggested that serum cytokine levels may
not be representative of local tissue inflammation, we
have measured the cytokine levels in lung homogenates in
parallel with the plasma (Fig. 4). In the lung, most of the
cytokines assayed (TNF-α, IL1-β, IL-4, IL-6, IL-8, and GM-
CSF) show maximum levels at 2 hrs after which they grad-
ually decrease, except for IL-10, which peaks at 8 hrs. The
plasma levels of these cytokines show a bimodal pattern,
with a first peak at 2 hrs followed by a second peak at 24
hrs, except for IL-4, which peaks at 8 hrs. Most cytokine
levels are higher in plasma than in lung tissue, with the
exception of IL-8, which is over 5 fold higher in the lung
than in the plasma, and IL-10, which is almost 2 times
higher in the lung at 8 hrs than in the plasma. Our data
demonstrate the existence of a lung specific cytokine pro-
file, and suggest that serum cytokine levels may not be
representative of local tissue inflammation and end-organ
damage.
7. Structural changes of the lung during E. coli sepsis
Histology and electron microscopy analysis demonstrate
gradual alteration of lung morphology. In contrast to the
normal architecture of the alveolar septae observed in
healthy baboons (Fig. 5a), marked accumulation of
inflammatory cells (especially neutrophils) within the
lung microvasculature was observed at 2 hrs (Fig. 5b).
Intermediate and late stages displayed various degrees of
interstitial edema due to capillary leakage into the alveo-
lar space, increased accumulation of macrophages, fibrob-
lasts and collagen deposition (Fig. 5c).
Discussions and Conclusion
Sepsis is a complex, multifactorial inflammatory dysregu-
lation occurring when the host is unable to effectively
control a bacterial infection. The disease eventually affects
the lungs, heart, liver and kidneys, through multiple
effects on endothelial, epithelial and immune cells.
Despite progress in understanding its pathophysiology,
sepsis is still a common disease with rising incidence and
mortality. Many promising therapeutic approaches that
were effective in animal studies failed to show similar
benefit in human clinical trials[29]. This may be due to
the fact that rodent models do not faithfully recapitulate
the human disease, or to improper staging of the disease
in animal models as compared with humans. Advances in
understanding the sequence of events and their specific
biomarkers during the progressive stages of sepsis would
increase the ability to define appropriate therapeutic tar-
gets and to define human populations for successful ther-
apeutic interventions. Our group has thoroughly
investigated the changes in plasma proteins during the
two-stage compensated response to sublethal inflamma-
tory E. coli challenge[30]. The first-stage of events occurred
within the first 4–6 hrs post-infusion and was character-
ized by massive production of vasoactive peptides and
cytokines, closely followed by activation of coagulation,
margination and activation of neutrophils, release of sym-
pathomimetic effectors, and leading to a transient micro-
vascular vasoconstriction and ischemia[17]. The second-
stage events occur after 12 hrs post challenge and include
post reperfusion oxidative stress, complement activation,
and a second round of hemostatic activity[17]. However,
the underlying sequence of changes in gene expression
after E. coli challenge at tissue level is unknown.
A major complication in sepsis is the progressively
impaired lung function, which often leads to acute lung
injury. Our aim was to understand the dynamics of theBMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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Ingenuity Pathway Analysis (IPA) of the differentially expressed genes at different time points after E. coli challenge Figure 3
Ingenuity Pathway Analysis (IPA) of the differentially expressed genes at different time points after E. coli chal-
lenge. Green indicates down-regulation and red indicates up-regulation. In this map all genes shown were statistically different 
from the control. A line indicates that two gene products show binding, a line terminated by arrow indicate that one gene 
product acts on the other gene product, and the plus sign indicate that other networks contain the gene product. The net-
works with the highest score in each time-point group are illustrated. a: IPA network 1 at 2 hrs; b: IPA network 1 at 8 hrs; c: 
IPA network 1 at 24 hrs. See the Additional files 2, 3, 4 for lists of genes involved in each network.BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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Cytokine quantitation in lung extracts and plasma of E. coli challenged baboons Figure 4
Cytokine quantitation in lung extracts and plasma of E. coli challenged baboons. TNF-α, IL-1β, IL-4, IL-6, IL-8, IL-10 
and G-CSF were assayed in lung lysates and plasma using a multiplex assay, as described in the Methods section. The values 
represent calculated as ratio per total protein in cell lysates or per ml of plasma, and presented as mean ± SD (n = 3). Asterisks 
(*) indicate p < 0.05 t-test values for lung and plasma samples of challenged animals (2, 8 and 24 hrs post E. coli infusion) vs. 
non-challenged controls.BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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specific changes in the transcriptional program of the lung
during the two stage inflammatory response to E. coli sep-
sis in baboons. The three time points selected, 2, 8 and 24
hours, represent the first, the transitional and the second
stage of the pathophysiological response to E. coli sepsis.
Identification of molecular fingerprints of the lung during
sepsis may facilitate the development of new approaches
for early diagnosis, treatment or prevention.
The baboon genome is not known yet; however, since the
similarity between the human and baboon genomes is
higher than 94%[22,31], and previous publications have
demonstrated that human DNA arrays can be effectively
cross-hybridized with monkey cDNA[22,23,31,32], we
used a human genome-specific oligonucleotide micro-
array to hybridize the baboon cDNA. We assume that the
human probes that are hybridized by the homologous
baboon cDNA provide valid information, while the non-
hybridized probe-sets can reflect either the absence of the
transcript or differences in the baboon sequence that pre-
vent hybridization. However, the use of pathway analysis
tools allows for the identification of networks of genes
that are known to interact with each other. This procedure
therefore provides confidence in the selected genes as well
as clues to what other genes may be regulated but not
identified as being significant by the microarray analysis.
We acknowledge two inherent limitations of our study.
First, as we have extracted total RNA from whole lungs,
our preparation contains transcripts originating from dif-
ferent cell types, therefore the spatial and cellular infor-
mation as to the origin of the signal is lost. To partially
overcome this limitation, we always have collected the tis-
sue from the same region of the lung both for RNA extrac-
tion and for histological and ultrastructural analysis. The
second limitation affects all gene array studies and derives
from the fact that one gene can encode multiple spliced
forms of transcripts, and further, the translated proteins
undergo various post-translation modifications.
Sequential induction of inflammatory and immune 
response genes
Sepsis involves an early strong activation of proinflamma-
tory networks, triggered by the exposure of the host to LPS
and other bacterial products. Most of the 35 genes that
were induced by E. coli at 2 hrs belong to the inflamma-
tory pathway and are regulated by, or interact with IL-1β
and IL-6. Except for decreased THBD and FABP5, the
remaining 33 genes are upregulated at this time-point.
It is clearly demonstrated both in humans and animal
models that cytokine production/release is a sequential
process. First, LPS induces proximal cytokines (TNF-α, IL-
1β) via the activation of NF-kB pathway[33], and these
two cytokines seem to mediate most of the patho-physio-
Electron microscopy analysis of structure changes in E. coli  challenged baboon lung Figure 5
Electron microscopy analysis of structure changes in 
E. coli challenged baboon lung. a: normal architecture of 
the alveolar septae in healthy baboons; b. accumulation of 
neutrophils (PMN) and the presence of intra-alveolar bleed-
ing erythrocytes (arrow) can be observed at 2 hrs; c: the 
increased accumulation of macrophages, fibroblasts and col-
lagen deposition at 24 hrs. av, alveola; coll, collagen; Fb, 
fibroblasts; Mac, macrophages; RBC, red blood cells. Magnifi-
cation: ×7000.BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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logical disturbances characteristic to sepsis. TNF-α is very
rapidly (within 60–90 min) induced when the inflamma-
tory response is initiated. As our earliest time point was 2
hrs, no up-regulation of TNF-α mRNA was detected. How-
ever, we have detected elevated levels of TNF-α in plasma
of E. coli challenged baboons, at all three time-points, as
well as the mRNA of a variety of inflammatory mediators
known to be regulated by TNF-α, including chemokines
(CXCL2, CXCL10, CXCL11, CCL2, CCL4, CCL20), adhe-
sive molecules (VCAM1, ICAM1, CEACAM8), cytokines
and their receptors (IL-1β, IL-6, IL-1RN, IL-15RA, CSF3),
TNFAIP2, TNFAIP3, TNIP1, the oxidative stress response
gene HP, SOD2 and other inflammatory response genes
S100A8, S100A9, NFKBIA, NFKBIE, GBP1, GBP2.
Next, proximal cytokines stimulate the production of dis-
tal cytokines IL-6 and IL-8 and/or anti-inflammatory
mediators like IL-10[34].
IL-6 regulates the expression of complement components
on endothelial cells and enhances cell function and pro-
duction of pro-inflammatory mediators[35]. IL-8 is a
potent activator and chemoattractant for neutrophils and
it is thought to mediate neutrophilic infiltrates in the
lung. In patients, high levels of IL-8 in broncho-alveolar
lavage fluid were found to be predictive for the develop-
ment of ARDS and were associated with high mortal-
ity[36]. In addition, IL-1β and TNF-α increase the
expression of specific subsets of chemokines and adhe-
sion molecules that appear to be involved in the patho-
genesis of lung injury. Expression of E-selectin and ICAM1
on the pulmonary endothelium and alveolar epithelial
cells enhances the adhesiveness of neutrophils to
endothelial cells, facilitates transmigration into interstitial
and distal airways and mediates the development of acute
capillary leaks[35]. Chemokines are involved in immune
and inflammatory responses where they act primarily as
chemoattractants and activators of specific leukocyte sub-
sets. CC chemokines positively enhance macrophage
function, leading to enhanced generation of CXC chem-
okines that results in chemoattraction of neutrophils into
lung interstitial and alveolar compartments[35]. We have
detected increased gene expression of three CX and four
CC chemokines. CXCL2 (MIP-2 α)-the highest expressed
chemokine (10.8-fold at 2 hrs)- is produced by activated
monocytes and neutrophils and expressed at sites of
inflammation, and is also induced in vitro by LPS treat-
ment of bronchoalveolar cells[37]. Two interferon γ-
induced CX chemokines were detected. CXCL10 (IP-10;
4.3-fold at 2 hrs) is chemotactic for monocytes and T lym-
phocytes, and CXCL11 (IP-9; 4.4-fold at 2 hrs and 10.5-
fold at 8 hrs) is an attractant for interleukin-activated T
cells but not for unstimulated T cells, neutrophils or
monocytes. CXCL11 induction by IFN-γ is enhanced by
TNF-α in monocytes, fibroblasts and endothelial cells.
Surprisingly, while several IFN-γ-induced genes were iden-
tified in this study, IFN-γ itself has not been detected. It is
known from previous studies published by this lab that
plasma levels of IFN-γ peak after 8 hrs post-challenge[38].
The lack of IFN-γ message could reflect a mismatch with
the human probe, or a low content of the lung in t cells
and antural killer cells, which are the main IFN γ-produc-
ing cells.
Among the CC chemokines, CCL20 (MIP 3α; over 8-fold
increase at 2 hrs) attracts lymphocytes and, slightly, neu-
trophils, but not monocytes. It is induced by LPS, TNF-α,
and IFN-γ and possesses antibacterial activity against E.
coli. CCL3L1 is the only chemokine that was found
increased at all three time-points. This is a chemotactic
agent for lymphocytes and monocytes and a known
inhibitor of HIV infection, but to date, no involvement in
E. coli sepsis has been reported. CXCL5 (LIX or ENA-78),
an attractant and activator of neutrophils, was the only
downregulated chemokine. Interestingly, this chemokine
was the highly expressed in a mouse model of LPS
induced acute lung injury[6]. The divergent expression
patterns for CXCL5 could reflect species-specific differ-
ences, or distinct responses to live bacteria vs. LPS chal-
lenge.
Two other inflammatory proteins, S100 calcium binding
protein, S100A8 (calgranulin A) and S100A9 (calgranulin
B), were among the highest expressed genes. S100A8 was
increased by 12.0, 27.5 and 6.2-fold at 2 hrs, 8 hrs and 24
hrs, respectively, while S100A9 was up-regulated 7.7 and
17.5-fold at 2 and 8 hrs, respectively. S100A8 and S100A9
are proinflammatory neutrophil modulatory proteins.
These proteins are found in the cytosol of neutrophils,
monocytes and differentiated macrophages in inflamed
tissues[39] as well as in the extracellular milieu during
inflammatory conditions[40,41], where may play role in
the recruitment and migration of neutrophils [42]. These
two calgranulins play an important signaling role by
inducing NF-kB activation and increased phosphorylation
of p38 and p44/42 MAP kinases. Similar to another mem-
ber of the calgranulin superfamily, S100A12, also referred
to as ENRAGE, S100A8 and S100A9 interact with cellular
RAGE on endothelium, mononuclear phagocytes, and
lymphocytes triggering cellular activation, and generation
of key proinflammatory mediators[43]. High levels of
serum S100A8 and S100A9 were reported in chronic
inflammation disorders, like rheumatoid arthritis, inflam-
matory bowel disease[44,45], bronchitis and tuberculo-
sis[46,47]. The increased expression of calgranulins may
reflect the large number of neutrophils and macrophages
that accumulate in the lung, and may serve as additional
molecular markers of early inflammatory response to
infection.BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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GBP1 and GBP2 are two members of the guanylate-bind-
ing protein (GBP) family of GTPases that are strongly
induced by IFN-  and other inflammatory cytokines.
GBP-1 mediates the inhibition of endothelial cell prolifer-
ation by inflammatory cytokines[48]. GBP-2 is expressed
by macrophages and has mainly a vesicular location. Both
proteins are considered as reliable markers of inflamma-
tory phenotype for endothelium and macrophages,
respectively[49,50]. GBP2 may also stimulate fibroblast
proliferation and fibrosis[51].
Consistent with prior studies[52], we found that early
proinflammatory response to sepsis in the lung is fol-
lowed by the transition to an anti-inflammatory state.
This is achieved by marked production of anti-inflamma-
tory mediators (DISIP, IL1RN, IL15RA, TNFAIP3, NFKBIA
and NFKBIE) and downregulation of proinflammatory
genes during the second stage of the disease (TNFRSF8,
CXCL5, C7, ITGB1BP1).
Our data demonstrating that IL-1 receptor antagonist is
upregulated in the early stages support a tight regulation
of pro- and anti-inflammatory responses in the lung. The
resulting balance may determine the outcome of the dis-
ease, as recent reports demonstrate an increased ratio of
IL-1 β to IL-1 receptor antagonist in patients with estab-
lished ARDS[53,54]. During the predominantly anti-
inflammatory stages, monocytes are deactivated, resulting
in decreased HLA-DRB3 and consequent reduced antigen
presentation, which is proposed as a major feature of sep-
sis-induced immunodepression[55]. Our data support a
transcriptional down-regulation of a panel of genes
required for MHC II-restricted antigen presentation that
may occur in the course of septic shock[56]. In macro-
phages, DISIP (delta sleep peptide, immunoreactor) plays
a role in the anti-inflammatory and immunosuppressive
effects of IL-10 by inhibiting NFKB1 nuclear transloca-
tion. Two important anti-inflammatory mediators, IL-4
and IL-10 showed no change at mRNA level, but were
detected by ELISA at 2 and 8 hrs respectively. This discrep-
ancy may reflect sequence differences between human
and baboon cDNA.
Coagulation
Thrombomodulin (THBD) is one of few genes that are
decreased at all 3 time points in this study. THBD is part
of the anticoagulant pathway that mediates the activation
of zymogen Protein C to activated Protein C (APC). APC
is an enzyme that inhibits thrombin generation by
degrading clotting factors Va and VIIIa, and regulates
inflammation by inhibiting leukocyte activation, thereby
reducing organ injury and microthrombus formation in
sepsis. It is well documented that sepsis promotes proco-
agulant activity by strong upregulation of tissue factor
(F3) paralleled by a decrease of tissue-associated THBD
due to TNF-dependent shedding into the plasma[57],
leading to the development of DIC associated with sepsis.
Hypoxia, oxidative stress and apoptosis
Oxidative stress occurs when a homeostatic balance
between the formation of reactive oxidizing oxygen spe-
cies and their removal by endogenous antioxidant scav-
enging compounds is disrupted[58]. Sepsis may lead to
oxidative stress either by excessive production of reactive
oxygen species including superoxide, hydrogen peroxide
and hydroxyl radicals and/or by inadequate antioxidative
defense, including superoxide dismutase (SOD), catalase,
vitamins C and E, and reduced glutathione[59]. One
symptom of severe sepsis is the impaired ability of tissue
to extract oxygen from the blood[60], leading to anaero-
bic metabolism.
Unexpectedly, we found that haptoglobin mRNA was
highly increased in the lung of septic baboons. This
plasma protein, normally produced by the liver, binds any
excess free iron, preventing bacteria from using the iron to
grow. In hemolysis, hemoglobin binds to haptoglobin to
form a complex that will be absorbed, thus preventing its
excretion into urine. Increased haptoglobin production
by the lung is a novel finding, and may be an adaptive
response to bacterial infection or may be partially due to
the limited hemolysis caused by sepsis. Two stress-induc-
ible proteins, SOD2 and TXNRD-1 are major scavengers
of reactive oxygen species[61] but also have anti-apoptotic
effects[62]. SOD2 is one of the key defense enzymes
induced in host to destroy dangerous reactive oxygen spe-
cies, such as superoxide radical (O2-) formed in the mito-
chondria as a byproduct of electron transport. It was
reported that TNF-α increased the level of thioredoxin and
SOD2 by a NF-kB dependent mechanism[63] and the
overexpression of SOD2 prevents apoptosis induced by
several oxidative stress inducers including TNF-α [64]. The
dramatic upregulation of these genes at 2 hrs may reflect
their role in counteracting the oxidative and proteolytic
potential of the incoming neutrophils. Apoptosis is a
highly regulated and evolutionarily conserved pro-
grammed process of cell death that is crucial for tissue
remodeling and plays a very important role in normal cell
regulation and in the pathology of sepsis[65]. Studies in
experimental animals and critically ill patients have dem-
onstrated that increased apoptosis of lymphoid organs
and parenchymal tissues contribute to the immune sup-
pression, anergy, and organ dysfunction. While lymphoid
cells are undergoing accelerated apoptosis, spontaneous
neutrophil apoptosis associated with sepsis or SIRS is
delayed[66,67]. This decreased apoptosis is thought to
actually enhance tissue injury in the lung by promoting a
disbalanced tissue load of neutrophils and uncontrolled
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release of toxic metabolites injurious to endothelial cells'
mitochondria and collagen deposition[66,68].
We have observed an increased expression of both pro-
and anti-apoptotic genes at 2 hrs, coinciding with maxi-
mum expression peak of cytokines and other inflamma-
tory mediators during the first stage. Conversely,
antiapoptotic and cell survival promoting genes (HIPK3,
MAPK8IP1, GTSE1, and DAP), were predominant during
the second stage (24 hrs) where tissue regeneration-spe-
cific processes are prevalent.
Extracellular matrix, tissue regeneration and functional 
recovery
Within the inflammatory process, a delicate balance exists
between the potential for tissue destruction and mecha-
nisms of protective immune defense and tissue repair.
Repair of wounded tissue involves a well-orchestrated
sequence of events involving infiltration of macrophages
that are essential for removal of necrotic cellular debris.
Further events include proliferation and migration of
parenchymal and connective tissue cells, extracellular
matrix deposition, tissue remodeling and angiogenesis.
Electron microscopy analysis of lung samples illustrates
that while the neutrophil migration is dominant during
the first hours post E. coli challenge, macrophage and
fibroblast accumulation and collagen deposition are the
foremost ultrastructural events during the second stage of
the response.
ECM remodeling and synthesis is controlled by de novo
synthesis and by the balance between proteolytic enzymes
and their inhibitors[69]. In this study, we observed down-
regulation of both MMP-2 and TIMP2 and 3 at 8 hrs and
24 hrs. MMP2 cleaves several collagens and plays a role in
regulation of vascularization and in the inflammatory
response. The decreased expressions of MMP2, its inhibi-
tor TIMP2 and of two collagen (type IV α1 and α3) com-
ponents of the capillary basement membrane suggest a
possible downregulation of angiogenesis in sepsis.
Besides its MMP inhibition effect, TIMP3 also inhibits
TNF-α converting enzyme (TACE), which cleave TNF-α
and regulates its shedding[70]. TIMP3 may have a protec-
tive role in the early stage by regulating TNF-dependent
systemic inflammation, as TIMP3 knocked out mice are
more susceptible to LPS-induced mortality[71]. The
observed decreased expression of TIMP3 during the sec-
ond stage may reflect the functional recovering post E. coli
challenge.
SERPINA3 (α1-antichymotrypsin), a serpin that can
inhibit potent proteases released by inflammatory cells,
was strongly induced at 8 hrs post challenge. In addition
to its role in matrix turnover, SERPINA3 may be also
involved in the regulation of vessel's tone. SERPINA3
inhibits neutrophil cathepsin G and mast cell chymase,
two proteases that convert angiotensin-1 to the active
angiotensin-2, therefore SERPINA3 upregulation may be
responsible for the reduced biological efficacy of the ren-
nin-angiotensin system, and thus contribute to the cardi-
ovascular collapse that occurs during sepsis. Our data
highlight SERPINA3 as a potential therapeutic target to
control the hemodynamic response of the vessel wall dur-
ing sepsis. Natriuretic peptide precursor C (NPPC) is
another vasoactive factor that we found to be upregulated
by sepsis. NPPC possesses potent natriuretic, diuretic, and
vasodilating activities and is implicated in body fluid
homeostasis and blood pressure control. Normally it is
expressed at low levels in endothelial cells, and its upreg-
ulation is a sign of endothelial dysfunction. The cardio-
vascular response to septic shock involves peripheral
vasodilatation resulting in reduced systemic vascular
resistance, hyporesponsiveness to vasopressors, and sys-
temic hypotension. While natriuretic peptide precursors A
and B were found in increased levels in septic patients and
are markers of poor outcome, currently no data on the
role of NPPC in sepsis have been published.
Many differentially expressed genes in the second stage of
sepsis are involved in clearing tissue debris present at the
wound site, or orchestrate aspects of tissue remodeling,
cell proliferation and angiogenic processes associated
with the wound response. This is particularly important,
as poor wound healing and recurrent infection contribute
to high mortality in septic patients[72]. Our data demon-
strate that genes involved in tissue repair are turned on as
early as 24 hrs after the onset of sepsis. While most of the
genes are induced during the second stage (12–24 hrs),
ACVR1B (activin receptor 1B), a TGF-β receptor with pro-
tein serine/threonine kinase activity was upregulated dur-
ing the first stage. Its early expression may be important
for mediating TGF activity during the second stage by par-
ticipating in activation of SMAD transcriptional regula-
tors. Activin upregulation in the lung after E. coli challenge
is also a novel finding but its role is the pathophysiology
of sepsis is not clear. In vitro studies support a role in the
repair of the mesenchyme and possibly also of the epithe-
lium, thus activin receptor upregulation could be benefi-
cial for the repair of damaged tissues. However, prolonged
and/or significantly increased expression of activin may
lead to involved the development of fibrosis, thus a tight
control of activin level is likely to be important for normal
repair[73].
The increased expression of genes such as FAP, FGF23,
FLT1 and TIE1 reflects the active tissue remodeling, regen-
eration and functional recovery at 24 hrs. Fibroblast acti-
vation protein α (FAP) is a membrane-bound gelatinase
involved in the control of fibroblast growth or epithelial-
mesenchymal interactions during tissue repair. FibroblastBMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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growth factor 23(FGF23) possesses broad mitogenic and
cell survival activities and is involved in cell growth and
tissue repair.
TIE1 is a tyrosine kinase receptor specifically expressed in
endothelial cells. Two angiopoietins, ANG1 and ANG4,
activate TIE1, thus supporting a role of TIE1 in angiogenic
remodeling[74]. Beside its angiopoietin-dependent func-
tion TIE1 has anti-apoptotic effects through downstream
activation of PI-3 kinase and Akt pathways[75]. FLT1
(VEGFR-1) is a tyrosine kinase receptor for VEGF, VEGF B
and PLGF that plays role in vascular development and reg-
ulation of vascular permeability. Recently, Yano et al
reported increased circulating levels of soluble FLT1 in
animal models and sepsis patients and suggested that cir-
culating FLT1 may represent an endogenous compensa-
tory anti-inflammatory mechanism[76]. The normal lung
tissue abundantly expresses VEGF, the ligand for FLT1.
VEGF is a HIF1-α-controlled endothelial mitogen that
mediates increased vascular permeability, induces angio-
genesis, vasculogenesis and endothelial cell growth, pro-
motes cell migration, and inhibits apoptosis. Like HIF- ,
VEGF expression was increased at 2 hrs, followed by an
unexpected decrease at 24 hr. Similar decreases in VEGF
mRNA and protein in lung autopsy material from septic
patients were reported[77]. However, the role of VEGF in
sepsis-induced lung injury is still not clear. Interestingly,
plasma levels of VEGF are increased during sepsis[78] and
may contribute to morbidity and mortality, but it is most
likely produced by other organs (heart, liver and kid-
neys)[76].
In summary, in this study we explored the changes in gene
expression that occur in the lung at selected time-points
following E. coli infusion in baboons. To our knowledge,
this is first time that the expression pattern of inflamma-
tion-associated genes and the transcriptional regulation of
sepsis-related genes were investigated in a temporal man-
ner in a baboon model. The baboon model mimics
human sepsis to a large extent, therefore our model offers
an important resource in the exploration of the pathways
and mechanisms involved in human sepsis. We found
that the primary inflammatory response genes, innate
immune response genes and some anti-apoptotic genes
peaked at 2 hrs. Another group of inflammatory response
genes and immune response genes that function as stimu-
lation of monocytes, natural killer and T-cell migration,
and modulation of adhesion molecule expression were
increased and peaked at 8 hrs, while genes involved in
wound healing and functional recovery were upregulated
at 24 hrs. The transition and late expression genes may
play important roles in survival. The global view of gene
transcripts profile in the lungs of septic animals will sig-
nificantly facilitate the understanding of the mechanism
of sepsis-induced lung failure, and the pathophysiology of
this disease. This may help exploring the development of
new drugs and finding new targets for therapeutic inter-
vention in severe sepsis.
Methods
Animal experimentation
The study protocol received prior approval by the Institu-
tional Animal Care and Use Committee. Experiments
were performed on 12 Papio cyanocephalus baboons. Nine
animals were infused with live E. coli (Type B7 086a:k62;
ATCC#33985, Rockville, MD) at the sublethal dose of 109
colony forming units (cfu)/kg and three were infused with
saline (control), as described[79]. Three animals per time-
point were sacrificed at 2, 8, and 24 hrs post-infusion.
Three control animals were sacrificed after saline infusion.
Lung tissue was collected from similar locations, snap-fro-
zen immediately in liquid nitrogen, and stored at -80°C
for mRNA and protein extraction. Adjacent lung tissue
was immersed in fixative and further prepared for histol-
ogy or electron microscopy.
RNA isolation
Total RNA was isolated from frozen lung tissues collected
from 12 baboons (control and 3 time-point groups; three
animals per group) using TRIzol reagent (Invitrogen, CA)
according to manufacturer's protocol. RNA concentration
was measured with a NanoDrop® ND1000 spectropho-
tometer (NanoDrop Technologies, Inc., Wilmington,
DE), and its integrity and purity were verified by using an
Agilent 2100 Bioanalyzer Capillary Gel Electrophoresis
System (Agilent, Palo Alto, CA).
Microarray slide
Microarrays were printed in-house using the Qiagen
Operon v2.0 human oligonucleotide library (21,329 oli-
gonucleotide probes) as previously described[80]. The 70-
nucleotide oligos were derived from the functionally
defined genes present in the UniGene database[81] and
their length and sequence specificity were optimized to
reduce the cross-hybridization problems encountered
with cDNA-based microarrays. The list of genes present on
the array is available[82]. All 11,000 human genes of
known or suspected function were represented on these
arrays. In addition, most undefined open reading frames
were represented (approximately 10,000 additional
genes). Oligonucleotides were spotted onto Corning®
UltraGAPS™ amino-silane-coated slides (Acton, MA,
USA), rehydrated with water vapor, snap-dried at 90°C,
and then covalently fixed to the surface of the glass using
300-mJ, 254-nm wavelength UV radiation. Unbound free
amines on the glass surface were blocked for 15 minutes
with moderate agitation in a 143 mM solution of succinic
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anhydride dissolved in 1-methyl-2-pyrolidinone, 20 mM
sodium borate, pH 8.0. Slides were rinsed for 2 minutes in
distilled water, immersed for 1 minute in 95% ethanol,
and dried with a stream of nitrogen gas.
Labeling and array hybridization
cDNA was synthesized from 10 μg of total RNA using
CyScribe cDNA Post Labeling Kit (Amersham, Piscataway,
NJ), labeled with Cy3 and purified using a Rapid PCR
Purification System (Marligen Bioscience Inc, Ijamsville,
MD) as previously reported[80]. Next, labeled cDNA was
added to ChipHybe™ hybridization buffer (Ventana Med-
ical Systems, Tucson, AR) containing Cot-1 DNA (0.5 mg/
ml final concentration), yeast tRNA (0.2 mg/ml), and
poly (dA)40–60 (0.4 mg/ml). Hybridization was per-
formed on a Ventana Discovery system for 6 hr at 42°C.
Microarrays were washed to a final stringency of 0.1× SSC,
and then scanned using an Agilent DNA Microarray Scan-
ner (Agilent Technologies, Santa Clara, CA). Fluorescent
intensity was measured by Imagene™ software (BioDis-
covery, Marina del Rey, CA).
Array analysis
Data normalization and robust regression was conducted
to correct for technical variation among individual micro-
array hybridizations. This was conducted using standard
statistical analysis methods in Matlab software, as
described[83,84]. Genes differentially expressed between
groups of samples were selected using associative analysis,
as previously described[83]. For selection of genes that
responded to E. coli challenge, each time point was com-
pared against controls (time 0). The fold ratio between
each time point (2, 8, and 24 hrs) versus control (time 0)
was generated using the average of normalized gene
expression values of three biological replica of each group.
The genes have a ratio either > 2 (up-regulated) or <0.5
(down-regulated) were selected as candidates for further
studies. Wards's hierarchical clustering was done using the
Spotfire DecisionSite for Functional Genomics 8.1 pack-
age (Spotfire, Inc., Somerville, MA, USA). Similarity meas-
ure was the Euclidean distance, the clustering method was
Unweighted Pair Group Method with Arithmetic Mean,
and input rank was the ordering function.
Real-Time RT-PCR
Real time quantitative PCR was conducted on ABI Prism
7000 Sequence Detection System (Applied Biosystems,
Foster City, CA). iTaqTM SYBR® Green Supermix (Bio-Rad,
CA) was used for detection and quantitation according to
manufacturer protocol. For a typical reaction, 12.5 μl of
iTaq SYBR Green 2× supermix, 10 μM of each primer and
equal or less than 200 ng of cDNA template were mixed
together and the final volume was adjusted to 25 μl.
Expression levels of β-actin were tested along with each
sample at each time point for normalization during the
relative quantification. Each gene was tested using two dif-
ferent cDNAs and the analysis was run in triplicate. The
default PCR conditions were as follows: (i) initiation: 2
min at 50°C; (ii) hot start of the enzyme: 10 min at 95°C;
(iii) amplification: denaturation at 95°C for 15 seconds,
followed by annealing and extension at 60°C for 1 min;
40 cycles. The specificity of gene PCR product was evalu-
ated by melt dissociation curve.
Pathway Analysis
Biologically relevant networks were drawn clusters of dif-
ferentially expressed genes. Pathways were generated
through the use of IPA software (Ingenuity Systems,
Mountain View, CA). The IPA uses the Ingenuity Pathways
Knowledge Base (IPKB), which is a curated database of
biological networks, consisting of millions of individu-
ally-modeled peer-reviewed pathway relationships. This
enabled the identification of sepsis-induced biologically
relevant networks by visual inspection.
Expression data sets containing gene identifiers (Entrez
Gene ID) and their corresponding expression values as
fold changes were uploaded in the IPA. Each gene identi-
fier was mapped to its corresponding gene object in the
Ingenuity Pathways Knowledge Base[85]. These "focus
genes" were then used as starting point for generating bio-
logical networks. The application program queries the
database for interactions between focus genes and all
other gene objects stored in the knowledge base, and gen-
erates a set of networks. Biological functions were
assigned to each gene network by using the findings
extracted from the published scientific literature and
stored in the Ingenuity Pathways Knowledge Base[85] and
are ranked according to the significance of that biological
function to the network. The program then computes a
score for each network according to the fit of the network
to the set of focus genes. The score is derived from a p-
value and indicates the likelihood of the focus genes in a
network being found together because of random chance.
A score of greater than 2 indicates that there is a less than
1 in 100 chance that the focus genes were assembled ran-
domly into a network due to random chance. In the cur-
rent study, a score of 6 (less than 1 in 1 million chances of
random grouping) or higher was used to select highly sig-
nificant biological networks regulated by E. coli sepsis.
Gene symbols were colored according to the temporal
behavior of their expression (red indicating up- and green
down-regulated expression).
Multiplex ELISA for inflammatory cytokines
Equal amounts of lung tissues were homogenized on ice
with 1% Triton X-100, 60 mM octyl-b-D glucopiranno-
side (OGP) in 50 mM Tris-HCl, 150 mM NaCl, pH 8.5,
supplemented with protease inhibitors (1.5 μM pepstatin
A, 10.5 μM leupeptin, 0.25 mM pefabloc SC, 20.9 μM cal-BMC Genomics 2007, 8:58 http://www.biomedcentral.com/1471-2164/8/58
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pain inhibitor I, 20 μM calpain inhibitor II, 1.5 μM apro-
tinin, 1 mM benzamidine, 1 mM EDTA, 1 mM sodium
ortho-vanadate, and 1 mM 1,10-phenanthroline). The
extracts were centrifuged at 14,500 × g for 15 min, and the
supernatants, representing the lung tissue lysates, were
collected and stored at -80°C. Total protein was deter-
mined using a BCA protein kit (Pierce, Rockford, IL). Ten
inflammatory cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8,
IL-10, IFN-γ, TNF-α, and GM-CSF) were measured using a
kit for human cytokines from BioSource International in
conjunction with a Luminex multiplex system (Luminex
Corporation)[86] and normalized to mg of total protein
for tissue extracts or to ml of plasma.
Morphological analysis
For electron microscopy, tissue samples were fixed with
glutaraldehyde and osmium tetraoxide, embedded in
epoxy resin and further prepared and examined as previ-
ously described[87].
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